Tag: Zhen Xu
-
Zhen Xu Receives Golden Goose Award from the American Association for the Advancement of Science
This award recognizes transformative work enabled by federal funding, which was crucial to advancing the tumor-destroying soundwaves until they were ready for the clinic.
-
Histotripsy Center Celebrates Opening, with Goal of Accelerating the Future of Non-Invasive Cancer Treatment
When histotripsy received FDA clearance for the noninvasive treatment of liver tumors in October 2023, it marked a milestone more than two decades in the making for University of Michigan researchers who helped pioneer the technology.
-
Zhen Xu Honored as a 2026 Recipient of the Sony Women in Technology Award with Nature
Dr. Xu was selected for her pioneering work as a co-inventor of the field of histotripsy.
-
Zhen Xu Receives Stephen S. Attwood Excellence in Engineering Award
Prof. Xu is a trailblazer in both clinical innovation and academic leadership through her research in the discovery of histotripsy, here at U-M.
-
Zhen Xu Named Finalist for 2026 Sony Women in Technology Award with Nature
This award recognizes three early to mid-career women researchers in technology whose work is driving positive impact on society and the planet. Winners will be announced in February.
-
U-M Startup HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors
The idea behind HistoSonics’ technology began decades ago at U-M in the Biomedical Engineering Department.
-
Researchers Are Examining Ways to Use Histotripsy to Stimulate the Immune System Against Cancer
Histotripsy can help release HER2 from cancer tumor cells.
-
Dr. Zhen Xu Receives Multiple Honors for Pioneering Work in Non-Invasive Cancer Treatment
Dr. Xu has been awarded the Li Ka-Shing Endowed Professorship in Biomedical Engineering, College of Engineering, effective December 1, 2024 through November 30, 2029.
-
Zhen Xu Receives IEEE Carl Hellmuth Hertz Ultrasonics Award
This is the highest honor for mid-career researchers in ultrasonics internationally.
-
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans
Technique developed at the University of Michigan provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.